BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/14/2023 6:13:55 AM | Browse: 68 | Download: 115
 |
Received |
|
2023-07-01 14:17 |
|
Peer-Review Started |
|
2023-07-01 14:19 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-07-06 08:47 |
|
Revised |
|
2023-07-16 16:05 |
|
Second Decision |
|
2023-08-31 02:06 |
|
Accepted by Journal Editor-in-Chief |
|
2023-09-05 09:50 |
|
Accepted by Company Editor-in-Chief |
|
2023-09-11 08:57 |
|
Articles in Press |
|
2023-09-11 08:57 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-11-06 09:00 |
|
Publish the Manuscript Online |
|
2023-11-14 06:13 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Methodology |
| Manuscript Type |
Review |
| Article Title |
Mesenchymal stem cells-based drug delivery systems for diabetic foot ulcer: A review
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Hong-Min Zhang, Meng-Liu Yang, Jia-Zhuang Xi, Gang-Yi Yang and Qi-Nan Wu |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Science and Health Joint Medical Research Project of Chongqing |
2022MSXM133 |
| Natural Science Foundation of Chongqing |
CSTB2022NSCQ-MSX1522 |
| Natural Science Foundation of Chongqing |
CSTB2023NSCQ-MSX0246 |
| Natural Science Foundation of Chongqing |
CSTB2022NSCQ-MSX1271 |
| Health Joint Project of Dazu District Science and Technology Bureau |
DZKJ,2022CCC1001 |
| The First Batch of Key Disciplines on Public Health in Chongqing and Science |
|
|
| Corresponding Author |
Qi-Nan Wu, Doctor, MD, Director, Professor, Department of Endocrinology, Dazu Hospital of Chongqing Medical University, The People's Hospital of Dazu, No. 1073 Second Ring South Road, Hongxing Community, Tangxiang Street, Dazu District, Chongqing 406230, China. wqn11@126.com |
| Key Words |
Diabetic foot ulcer; Mesenchymal stem cells; Drug delivery systems; Diabetes; Wound healing |
| Core Tip |
Diabetic foot ulcer (DFU) is a significant concern due to its association with high rates of disability and mortality. Mesenchymal stem cell (MSC) therapy has been extensively studied in treating DFU, the current efficacy of DFU healing using this method is still inadequate. However, in recent years, several MSCs-based drug delivery systems have emerged, which have shown to increase the efficacy of MSC therapy, especially in treating DFU. |
| Publish Date |
2023-11-14 06:13 |
| Citation |
Zhang HM, Yang ML, Yang GY, Wu QN. Mesenchymal stem cells-based drug delivery systems for diabetic foot ulcer: A review. World J Diabetes 2023; 14(11): 1585-1602 |
| URL |
https://www.wjgnet.com/1948-9358/full/v14/i11/1585.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v14.i11.1585 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
